Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug users

References

• Arnsten , J. H. , Demas , P. A. , Grant , R. W. , Gourevitch , M. N. , Farzadegan , H. , Howard , A. A. and Schoenbaum , E. E. 2002 . Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users . Journal of General Internal Medicine , 17 : 377 – 81 .
   PubMed Web of Science ®Google Scholar
• Clarke , S. M. and Mulcahy , F. M. 2000 . Antiretroviral therapy for drug users . International Journal of STD & AIDS , 11 : 627 – 31 .
   PubMed Web of Science ®Google Scholar
• Dronda , F. , Moreno , S. , Moreno , A. , Casado , J. L. , Perez-Elias , M. J. and Antela , A. 2002 . Long-term outcomes among antiretroviral-naive human immunodeficiency virus-infected patients with small increases in CD4+ cell counts after successful virologic suppression . Clinical Infectious Diseases , 35 : 1005 – 1009 .
   PubMed Web of Science ®Google Scholar
• Dronda , F. , Zamora , J. , Moreno , S. , Moreno , A. , Casado , J. L. , Muriel , A. , Perez-Elias , M. J. , Antela , A. , Moreno , L and Quereda , C. 2004 . CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients: the role of intravenous drug use . AIDS , 18 : 2210 – 12 .
   PubMed Web of Science ®Google Scholar
• Grabar , S. , Le M , V. , Goujard , C. , Egger , M. , Leport , C. , Kazatchkine , M. D. , Weiss , L. and Costagliola , D. 2005 . Response to highly active antiretroviral therapy at 6 months and long-term disease progression in HIV-1 infection . Journal of Acquired Immune Deficency Syndromes , 39 : 284 – 92 .
   PubMed Web of Science ®Google Scholar
• Grabar , S. , Le M , V. , Goujard , C. , Leport , C. , Kazatchkine , M. D. , Costagliola , D. and Weiss , L. 2000 . Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy . Annals of Internal Medicine , 133 : 401 – 10 .
   PubMed Web of Science ®Google Scholar
• Greub , G. , Ledergerber , B. , Battegay , M. , Grob , P. , Perrin , L. , Furrer , H. , Burgisser , P. , Erb , P. , Boggian , K. , Piffaretti , J. C. , Hirschel , B. , Janin , P. , Francioli , P. , Flepp , M. and Telenti , A. 2000 . Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study . Lancet , 356 : 1800 – 1805 .
   PubMed Web of Science ®Google Scholar
• Kapadia , F. , Vlahov , D. , Donahoe , R. M. and Friedland , G. 2005 . The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations . Clinical Infectious Diseases , 41 : 1027 – 34 .
   PubMed Web of Science ®Google Scholar
• Lucas , G. M. , Cheever , L. W. , Chaisson , R. E. and Moore , R. D. 2001 . Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection . Journal of Acquired Immune Deficency Syndromes , 27 : 251 – 59 .
   PubMed Web of Science ®Google Scholar
• Lucas , G. M. , Griswold , M. , Gebo , K. A. , Keruly , J. , Chaisson , R. E. and Moore , R. D. 2006 . Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy . American Journal of Epidemiology , 163 : 412 – 20 .
   PubMed Web of Science ®Google Scholar
• Lucas , G. M. , Weidle , P. J. , Hader , S. , & Moore , R. D. ( 2004 ). Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study . Clinical Infectious Diseases , 38 Suppl 5 : S409-13 ., S409 – S413 .
   PubMed Web of Science ®Google Scholar
• Mellors , J. W. , Munoz , A. , Giorgi , J. V. , Margolick , J. B. , Tassoni , C. J. , Gupta , P. , Kingsley , L. A. , Todd , J. A. , Saah , A. J. , Detels , R , Phair , JP and Rinaldo , CR Jr . 1997 . Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection . Annals of Internal Medicine , 126 : 946 – 54 .
   PubMed Web of Science ®Google Scholar
• Mellors , J. W. , Rinaldo , C. R. Jrx , Gupta , P. , White , R. M. , Todd , J. A. and Kingsley , L. A. 1996 . Prognosis in HIV-1 infection predicted by the quantity of virus in plasma . Science , 272 : 1167 – 70 .
   PubMed Web of Science ®Google Scholar
• Mocroft , A. , Madge , S. , Johnson , A. M. , Lazzarin , A. , Clumeck , N. , Goebel , F. D. , Viard , J. P. , Gatell , J. , Blaxhult , A. and Lundgren , J. D. 1999 . A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival . Journal of Acquired Immune Deficency Syndromes , 22 : 369 – 78 .
   PubMed Web of Science ®Google Scholar
• Mocroft , A. , Vella , S. , Benfield , T. L. , Chiesi , A. , Miller , V. , Gargalianos , P. , d'Arminio , M. A. , Yust , I. , Bruun , J. N. , Phillips , A. N. and Lundgren , J. D. 1998 . Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group . Lancet , 352 : 1725 – 30 .
   PubMed Web of Science ®Google Scholar
• Moore , D. M. , Hogg , R. S. , Yip , B. , Wood , E. , Tyndall , M. , Braitstein , P. and Montaner , J. S. 2005 . Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy . Journal of Acquired Immune Deficency Syndromes , 40 : 288 – 93 .
   PubMed Web of Science ®Google Scholar
• Nicastri , E. , Chiesi , A. , Angeletti , C. , Sarmati , L. , Palmisano , L. , Geraci , A. , Andreoni , M. and Vella , S. 2005 . Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART . Journal of Medical Virology , 76 : 153 – 60 .
   PubMed Web of Science ®Google Scholar
• Palella , F. J. Jr , Delaney , K. M. , Moorman , A. C. , Loveless , M. O. , Fuhrer , J. , Satten , G. A. , Aschman , D. J. and Holmberg , S. D. 1998 . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators . New England Journal of Medicine , 338 : 853 – 60 .
   PubMed Web of Science ®Google Scholar
• Palepu , A. , Tyndall , M. , Yip , B. , O'Shaughnessy , M. V. , Hogg , R. S. and Montaner , J. S. 2003 . Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use . Journal of Acquired Immune Deficency Syndromes , 32 : 522 – 26 .
   PubMed Web of Science ®Google Scholar
• Piketty , C. , Weiss , L. , Thomas , F. , Mohamed , A. S. , Belec , L. and Kazatchkine , M. D. 2001 . Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen . Journal of Infectious Diseases , 183 : 1328 – 35 .
   PubMed Web of Science ®Google Scholar
• Pontali , E. 2005 . Antiretroviral treatment in correctional facilities . HIV Clinical Trials , 6 : 25 – 37 .
   PubMed Web of Science ®Google Scholar
• Rich , J. D. , Holmes , L. , Salas , C. , Macalino , G. , Davis , D. , Ryczek , J. and Flanigan , T. 2001 . Successful linkage of medical care and community services for HIV-positive offenders being released from prison . Journal of Urban Health , 78 : 279 – 89 .
   PubMed Web of Science ®Google Scholar
• Roca , B. , Gomez , C. J. and Arnedo , A. 1999 . Stavudine, lamivudine and indinavir in drug abusing and non-drug abusing HIV-infected patients: adherence, side effects and efficacy . Journal of Infection , 39 : 141 – 45 .
   PubMed Web of Science ®Google Scholar
• Rosen , D. L. , Golin , C. E. , Schoenbach , V. J. , Stephenson , B. L. , Wohl , D. A. , Gurkin , B. and Kaplan , A. H. 2004 . Availability of and access to medical services among HIV-infected inmates incarcerated in North Carolina county jails . Journal of Health Care for the Poor and Underserved , 15 : 413 – 25 .
   PubMed Web of Science ®Google Scholar
• Springer , S. A. , Pesanti , E. , Hodges , J. , Macura , T. , Doros , G. and Altice , F. L. 2004 . Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community . Clinical Infectious Diseases , 38 : 1754 – 60 .
   PubMed Web of Science ®Google Scholar
• Vlahov , D. , Anthony , J. C. , Munoz , A , Margolick , J , Nelson , KE , Celentano , DD , Solomon , L and Polk , BF. 1991 . The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants . NIDA Research Monograph , 109 : 75 – 100 .
   PubMedGoogle Scholar
• Vlahov , D. , Galai , N. , Safaeian , M. , Galea , S. , Kirk , G. D. , Lucas , G. M. and Sterling , T. R. 2005 . Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection . American Journal of Epidemiology , 161 : 999 – 1012 .
   PubMed Web of Science ®Google Scholar
• Vlahov , D. , Graham , N. , Hoover , D. , Flynn , C. , Bartlett , J. G. , Margolick , J. B. , Lyles , C. M. , Nelson , K. E. , Smith , D. , Holmberg , S. and Farzadegan , H. 1998 . Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count . Journal of the American Medical Association , 279 : 35 – 40 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Montaner , J. S. , Yip , B. , Tyndall , M. W. , Schechter , M. T. , O'Shaughnessy , M. V. and Hogg , R. S. 2003 . Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users . Canadian Medical Association Journal , 169 : 656 – 61 .
   PubMed Web of Science ®Google Scholar
• Zaccarelli , M. , Barracchini , A. , De Longis , P. , Perno , C. F. , Soldani , F. , Liuzzi , G. , Serraino , D. , Ippolito , G. and Antinori , A. 2002 . Factors related to virologic failure among HIV-positive injecting drug users treated with combination antiretroviral therapy including two nucleoside reverse transcriptase inhibitors and nevirapine . AIDS Patient Care & STDS , 16 : 67 – 73 .
   PubMed Web of Science ®Google Scholar